Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 45 Women only

Comparing Norepinephrine and Phenylephrine for Blood Pressure Control During Cesarean Delivery

Official title: Manually Controlled Continuous Infusion of Norepinephrine vs Phenylephrine During Spinal Anesthesia for Cesarean Section: A Double-blinded Randomized Controlled Study

Run by Hassan II University · NCT06248593 · Data updated 2026-11-12

This study is testing whether using norepinephrine instead of phenylephrine can better control blood pressure during cesarean deliveries with spinal anesthesia.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment140 (estimated)
SponsorHassan II University
Academic / other
Locations2 sites (Fes and 1 other locations)
StatusRecruiting
StartedJanuary 29, 2025
Main results expectedMarch 15, 2026
Study endsMarch 15, 2026
Registry record updatedSeptember 9, 2025
Trial IDNCT06248593 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include full-term, singleton, non-laboring pregnant women scheduled for elective cesarean delivery under spinal anesthesia with stable baseline blood pressure.

Probably not a fit

Patients with known fetal abnormalities, preexisting hypertension, or contraindications to spinal anesthesia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effects of continuous infusion of norepinephrine versus phenylephrine on blood pressure maintenance during spinal anesthesia for elective cesarean sections. It is a randomized, double-blind, two-arm, parallel, non-inferiority trial conducted at Hassan II University Hospital in Fes, Morocco. Participants will receive either norepinephrine or phenylephrine, with infusion rates adjusted based on maternal arterial pressure, to assess differences in neonatal outcomes and maternal hemodynamics.

Why it matters

Potential benefit: If successful, this study could improve blood pressure management during cesarean deliveries, leading to better outcomes for both mothers and their newborns.

How similar studies have gone: Previous studies have shown varying results with similar approaches, but this specific comparison of norepinephrine and phenylephrine in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Full-term, singleton, pregnant women, nonlaboring.
* Scheduled for elective cesarean delivery under spinal anesthesia,
* American Society of Anesthesiologists physical status : 1 or 2
* Baseline systolic BP between 90 and 140 mm Hg.

Exclusion Criteria:

* Known fetal abnormality.
* Preexisting or pregnancy-induced hypertension, cardiovascular, cerebrovascular or kidney disease.
* Contraindication to spinal anesthesia.
* Peripartum hemorrhage.
* Body mass index above 40 kg/m2.

Where it's running

  • University hospital Hassan II
    Fes, Morocco
    Recruiting
  • University hospital Hassan II
    Fes, Morocco
    Not yet recruiting

Study contacts

  • Principal investigator: Mohamed Adnane Berdai, MD-PhD — University hospital Hassan II, Fes, Morocco
  • Study coordinator: Mohamed Adnane Berdai, MD-PhD
  • Email: adnane.berdai@yahoo.fr
  • Phone: +212655260752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.